Bill Text: CT SB00021 | 2015 | General Assembly | Comm Sub

---

Bill Title: An Act Requiring The Insurance Commissioner To Study Opioid Analgesics.

Spectrum: Committee Bill

Status: (Introduced - Dead) 2015-05-30 - Referred by Senate to Committee on Appropriations [SB00021 Detail]

Download: Connecticut-2015-SB00021-Comm_Sub.html

---

General Assembly		Committee Bill No. 21
January Session, 2015		LCO No. 5039
		*_____SB00021INS___031915____*
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
(INS)

AN ACT REQUIRING THE INSURANCE COMMISSIONER TO STUDY OPIOID ANALGESICS.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

Section 1. (Effective from passage) The Insurance Commissioner shall study abuse-deterrent opioid analgesics and nonabuse-deterrent opioid analgesics. Such study shall include, but not be limited to, (1) the health insurance coverage in this state for each type of opioid analgesic, (2) the frequency of dispensation of each type of opioid analgesic over the twelve months immediately preceding, to the extent determinable, (3) manufacturer cost comparisons between each type of opioid analgesic, (4) comparisons of out-of-pocket expenses to insureds in this state for each type of opioid analgesic, and (5) the availability of generic abuse-deterrent opioid analgesics, including a summary of any guidance document published on the subject during the year by the federal Food and Drug Administration. Not later than February 1, 2016, the Insurance Commissioner shall submit a report, in accordance with the provisions of section 11-4a of the general statutes, to the joint standing committee of the General Assembly having cognizance of matters relating to insurance.

This act shall take effect as follows and shall amend the following sections:
Section 1	from passage	New section

INS

Joint Favorable